Nautilus Biotechnology Current Cash

Nautilus Biotechnology (NAUT) currently reports a current cash of $13M as of June 2026. That compares with $34M in the prior-year period — down 61.8% year over year. Use the charts on this page to explore Nautilus Biotechnology's current cash history and peer comparisons.

Nautilus Biotechnology's current cash decreased from $34M to $13M — a 61.8% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Nautilus Biotechnology reported $13M in current cash as of June 2026. That compares with $34M in the prior-year period — down 61.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $13M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Nautilus Biotechnology, and consider following NAUT for alerts when major investors trade the stock.

Nautilus Biotechnology is classified in the Healthcare sector. On current cash, it currently shows $13M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NAUT with unrelated industries.